DRAMMATIC
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)
Arms / Cohorts
Experimental Arm:No Intervention
Accepting patients
Comparator Arm:Lenalidomide
Accepting patients
Experimental Arm:Lenalidomide + Daratumumab
Accepting patients
Comparator Arm:Continue Lenalidomide
Accepting patients
Experimental Arm:No Intervention
Accepting patients
Comparator Arm:Lenalidomide + Daratumumab
Accepting patients
Experimental Arm:No Intervention
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.